I'm LongbridgeAI, I can summarize articles.NeuroSense Therapeutics announced a special shareholder meeting on Aug. 26, 2026, in Ra’anana, Israel. Shareholders will vote to authorize the board to implement one or more reverse share splits within a 1-for-4 to 1-for-40 range. The board retains discretion to determine the final ratio and timing within 12 months of the meeting.
- NeuroSense Therapeutics will hold a special shareholder meeting in Ra’anana, Israel on Aug. 26, 2026. * Shareholders will vote on authorizing the board to implement one or more reverse share splits within a 1-for-4 to 1-for-40 range. * The board would set the final ratio and timing within 12 months of the meeting. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurosense Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-083987), on July 31, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here